HRMY · Harmony Biosciences Holdings, Inc.
AI read · Neutral
The AI's read
The incoming chief already runs operations, and Dayno is expected to remain as an adviser through January 2028. The filing sets a $725,000 annual salary and eligibility for $2.5 million in stock awards for the new chief, adding costs. It reports no change in business results, so these leadership terms alone do not point to a change in the company's business.